FIELD: chemistry.
SUBSTANCE: present invention relates to new compounds of formula (I), to pharmaceutically acceptable compositions containing these compounds and to methods for using the compositions for treating cancer. (I).
EFFECT: obtained new compounds suitable to be used as inhibitors of DNA-PK.
64 cl, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
DNA-PK INHIBITORS | 2013 |
|
RU2638540C1 |
ISOINDOLINONE-BASED PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | 2010 |
|
RU2573569C2 |
PESTICIDE COMPOSITIONS AND RELATED METHODS | 2013 |
|
RU2651369C1 |
AZETIDINYL DIAMIDES AS MONOACYLGLICEROL LIPASE INHIBITORS | 2010 |
|
RU2569298C2 |
AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LYPASE INHIBITORS | 2010 |
|
RU2549547C2 |
ORALLY BIOAVAILABLE PRODRUGS OF (+)-3-HYDROXYMORPHINAN FOR PREVENTING OR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2430089C2 |
CYCLIC AMINE COMPOUNDS | 2002 |
|
RU2299207C2 |
PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | 2015 |
|
RU2687160C2 |
DERIVATIVES OF 5,6-DIHYDROPYRONE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1994 |
|
RU2140917C1 |
TAXANE DERIVATIVE PHOSPHONOOXYMETHYL ESTERS, INTERMEDIATE COMPOUNDS, ANTITUMOR PHARMACEUTICAL COMPOSITION, METHOD OF TUMOR GROWTH SUPPRESSION IN MAMMALS | 1993 |
|
RU2136673C1 |
Authors
Dates
2018-12-27—Published
2014-03-12—Filed